12:00 AM
 | 
Aug 14, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Pharmacia preclinical data

Researchers at PHA's Sugen Inc. subsidiary (South San Francisco, Calif.) and colleagues published in the Proceedings of the National Academy of Sciences that daily treatment with 50 mg/kg AG-1478, an inhibitor...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >